Single‐Atom Enzymes: From Evolutionary Insights, Precision Engineering to Breakthroughs in Biomedical Applications
Small · 2025-09 · 21 (37)
DOI: 10.1002/smll.202505750 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 03.08.2025. Verfasst von Ye Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China. Hauptthemen laut MEDLINE: Enzymes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 156 Literaturangaben. Gefördert von: National Natural Science Foundation of China, "Clinic Plus" Outstanding Project from Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, the Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation under Grant Number.
Abstract (Originalsprache)
Single‐atom enzymes (SAEs), integrating the catalytic efficiency of single‐atom catalysts with enzymatic functions, represent a paradigm shift in biomedicine. Comprising natural enzymes, mimic enzymes, and single‐atom nanozymes, SAEs leverage isolated metal atoms as catalytic centers. Natural enzymes, evolved over billions of years, feature monoatomic active sites for precise biocatalysis under physiological conditions. Mimic enzymes (e.g., DNAzymes) represent a biomimetic adaptation, replicating natural active sites via programmable molecular scaffolds to enhance stability while inheriting an evolutionary bias that prioritizes structural robustness over catalytic diversity, limiting multifunctionality. In contrast, nanozymes embody an evolutionary leap: they sacrifice partial biocompatibility to achieve multienzyme‐mimicking capabilities and scalable production through inorganic nanomaterial engineering, thereby expanding the catalytic landscape beyond biological boundaries, though this advancement introduces concomitant immunogenicity challenges. This review systematically examines cutting‐edge advances in SAE applications across biomedical domains including biosensing, oncotherapy, antimicrobial strategies, and oxidative stress management. This review particularly presents a critical analysis of current challenges and emerging opportunities, proposing rational design principles for next‐generation SAEs with enhanced multifunctionality. By elucidating fundamental design strategies and translational potential, this work aims to accelerate the development of precision catalytic platforms for modern biomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
ORCID-Profile: Yu Yang, Weihong Tan
Förderung
- National Natural Science Foundation of China
- "Clinic Plus" Outstanding Project from Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine
- the Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation under Grant Number
- China Postdoctoral Science Foundation
Zitieren
APA
Xu, Y., Dong, C., Liu, X., Wei, D., Chen, Z., Zhou, H., Li, J. B., Yang, Y., & Tan, W. (2025). Single‐Atom Enzymes: From Evolutionary Insights, Precision Engineering to Breakthroughs in Biomedical Applications. Small, 21(37). https://doi.org/10.1002/smll.202505750
Vancouver
Xu Y, Dong C, Liu X, Wei D, Chen Z, Zhou H, et al. Single‐Atom Enzymes: From Evolutionary Insights, Precision Engineering to Breakthroughs in Biomedical Applications. Small. 2025;21(37). doi:10.1002/smll.202505750
BibTeX
@article{Xu2025,
author = {Xu, Ye and Dong, Chuhuang and Liu, Xueliang and Wei, Dali and Chen, Zhejie and Zhou, Huayuan and Li, Jia-Bei and Yang, Yu and Tan, Weihong},
title = {Single‐Atom Enzymes: From Evolutionary Insights, Precision Engineering to Breakthroughs in Biomedical Applications},
journal = {Small},
year = {2025},
volume = {21},
number = {37},
doi = {10.1002/smll.202505750}
}
EUVIMED